FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions.

Qamar S, Wang G, Randle SJ, Ruggeri FS, Varela JA, Lin JQ, Phillips EC, Miyashita A, Williams D, Ströhl F, Meadows W, Ferry R, Dardov VJ, Tartaglia GG, Farrer LA, Kaminski Schierle GS, Kaminski CF, Kaminski CF, Holt CE, Fraser PE, Schmitt-Ulms G, Klenerman D, Knowles T, Vendruscolo M, St George-Hyslop P. · 2018

Read FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions. by Qamar S, Wang G, Randle SJ, Ruggeri FS, Varela JA, Lin JQ, Phillips EC, Miyashita A, Williams D, Ströhl F, Meadows W, Ferry R, Dardov VJ, Tartaglia GG, Farrer LA, Kaminski Schierle GS, Kaminski CF, Kaminski CF, Holt CE, Fraser PE, Schmitt-Ulms G, Klenerman D, Knowles T, Vendruscolo M, St George-Hyslop P. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5927716.txt.

Introduction

Qamar and co-authors show how a chaperone and methylation tune FUS phase separation. Their article appeared in Cell. FUS is an RNA-binding protein in membrane-free granules. It can shift between loose, droplet, and gel states. Forces between its tyrosine and arginine parts help drive that shift. Arginine methylation normally tempers those forces.

Low methylation strongly promoted clumping and gel formation, they report. Such low methylation occurs in a form of frontal brain disease. The gels disrupted granule work and new protein making. A transport protein acted as a natural chaperone against this. It rescued protein synthesis in nerve terminals. The work links a chemical mark to disease.

Catalog record

CREATORQamar S, Wang G, Randle SJ, Ruggeri FS, Varela JA, Lin JQ, Phillips EC, Miyashita A, Williams D, Ströhl F, Meadows W, Ferry R, Dardov VJ, Tartaglia GG, Farrer LA, Kaminski Schierle GS, Kaminski CF, Kaminski CF, Holt CE, Fraser PE, Schmitt-Ulms G, Klenerman D, Knowles T, Vendruscolo M, St George-Hyslop P.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE94 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5927716

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions By Seema Qamar, GuoZhen Wang, Suzanne J Randle, Francesco Simone Ruggeri, Juan A Varela, Julie Qiaojin Lin, Emma C Phillips, Akinori Miyashita, Declan Williams, Florian Ströhl, William Meadows, Rodylyn Ferry Published in: Cell DOI: 10.1016/j.cell.2018.03.056 ABSTRACT Summary Reversible phase separation underpins the role of FUS in ribonucleoprotein granules and other membrane-free organelles and is, in part, driven by the intrinsically disordered low-complexity (LC) domain of FUS. Here, we report that cooperative cation-π interactions between tyrosines in the LC domain and arginines in structured C-terminal domains also contribute to phase separation. These interactions are modulated by post-translational arginine methylation, wherein arginine hypomethylation strongly promotes phase separation and gelation. Indeed, significant hypomethylation, which occurs in FUS-associated frontotemporal lobar degeneration (FTLD), induces FUS condensation into stable intermolecular β-sheet-rich hydrogels that disrupt RNP granule function and impair new protein synthesis in neuron terminals. We show that transportin acts as a physiological molecular chaperone of FUS in neuron terminals, reducing phase separation and gelation of methylated and hypomethylated FUS and rescuing protein synthesis. These results demonstrate how FUS condensation is physiologically regulated and how perturbations in these mechanisms can lead to disease. Keywords: phase separation, neuronal ribonucleoprotein granule, synaptic new protein synthesis, membraneless organelle, cation-π, arginine methylation, citrullination, frontotemporal dementia, AFM-IR, phase-sensitive fluorescent dyes INTRODUCTION Fused in sarcoma (FUS) is an RNA-binding protein involved in RNA transcription, splicing, transport, and translation. FUS undergoes rapid, physiologically reversible phase separation between dispersed, liquid droplet, and hydrogel states (Han et al., 2012, Kato et al., 2012, Murakami et al., 2015, Patel et al., 2015). The droplet and hydrogel states are stabilized by hydrogen bonding between antiparallel β sheet motifs formed by core residues 39–95 in the low-complexity (LC) domain (Murray et al., 2017) (Figure 1A). The ability of FUS and other proteins with intrinsically disordered domains to undergo phase separation likely contributes to the role of FUS in forming transient membrane-free organelles, such as ribonucleoprotein (RNP) granules (Weber and Brangwynne, 2012). These dynamic structures take up, sequester, transport, and then release key RNA and protein cargos that regulate local RNA and protein metabolism in subcellular niches, such as axon terminals and dendrites (Holt and Schuman, 2013, Sephton and Yu, 2015). When these processes go awry (e.g., because of pathogenic missense mutations), they trigger disease, such as familial amyotrophic lateral sclerosis (fALS) and frontotemporal lobar degeneration (FTLD). [Figure: Phase Separation of Full-Length FUS at Physiological Temperature and Protein Concentration Is Modulated by Salt Concentration and Arginine Methylation(A) Left: Schematic of domain architecture and location of tyrosine-rich and arginine-rich domains. Right: Arginine methylation species. RRM, RNA recognition motif; RRG, arginine glycine-rich domain.(B) Salt-dependent phase separation of ADMA FUS and HYPO FUS. Top: Representative images of phase separation of 1 μM EmGFP-tagged ADMA FUS in 50–150 mM NaCl. At 150 mM NaCl, ADMA FUS is mono-dispersed, but phase separates into spherical droplets at lower salt concentrations. Middle: Representative images of ADMA FUS for KCl concentrations of 50–150 mM. Bottom: Identically prepared HYPO FUS phase separates at higher salt concentrations (100 mM) into small, irregularly shaped condensates. White boxes indicate location of magnified images in (C). Scale bar, 25 μm.(C) High-magnification images of condensates from (B). Scale bar, 5 μm.(D) Quantitative analysis of sphericity: ADMA FUS condensates (gray) in 50 mM NaCl are spherical. HYPO FUS condensates (red) are less spherical (t = 3.47, p = 0.0006). n ≥ 121 particles/FUS subtype; n > 3 independent replications. Error bars, SEM.(E) Sequential structured illumination microscopy images of individual droplet collisions at 0, 200, and 680 ms. ADMA FUS (top) fuse. HYPO FUS collide but do not fuse. Scale bar, 2 μm. See Video S1 (ADMA FUS) and Video S2 (HYPO FUS).(F) Representative images and quantitative turbidity graphs of phase separation arising from mixing EmGFP-tagged ADMA FUS with the indicated percentage of fully unmethylated UM FUS. Preparations containing > 1% UM FUS form small non-spherical, non-fusing, and amorphous assemblies. Scale bar, 25 μm. Two-way ANOVA with Bonferroni post hoc test versus ADMA FUS at 40 mM, n ≥ 3 replications, ∗∗p < 0.01, ∗∗∗p < 0.001. Error bars, SEM.See also Figure S1 and Videos S1 and S2.] Given the crucial role of intrinsically disordered proteins like FUS in multiple fundamental biological processes, understanding the molecular and cellular factors that control their reversible condensation would be invaluable. This knowledge could also yield avenues for therapeutic intervention in diseases associated with aberrant assembly of these proteins, such as FUS-associated ALS (fALS-FUS) and frontotemporal lobar degeneration (FTLD-FUS). A potentially powerful clue to the identity of such factors is the observation that arginines in FUS, which are predominantly located in the structured C-terminal domain (sCTD), are normally heavily methylated as mono- or dimethylated forms (Figure 1A) (Rappsilber et al., 2003). However, in FTLD-FUS, FUS is hypomethylated and accumulates in neurons as nuclear and cytoplasmic aggregates that frequently also contain EWS, TAF15, and transportin 1 (TNPO1) (Dormann et al., 2012, Neumann et al., 2012). These observations suggest that physiological fluctuations in its arginine methylation and/or its interactome might physiologically control FUS phase behavior. To assess this possibility, we investigated the effect of manipulating (1) the number and post-translational methylation state of arginines (Figure 1A) and (2) the interactions with known FUS-binding proteins. These experiments confirm that FUS phase separation is exquisitely modulated by (1) arginine methylation state (which tunes the strength of cation-π interactions between the structured C-terminal and the disordered N-terminal domains) and (2) binding of TNPO1, which acts as a molecular chaperone in peripheral compartments of neurons. Crucially, hypomethylation of FUS promotes formation of stable condensates comprising intermolecular β-sheet-rich FUS assemblies that disrupt RNP granule function in neuronal terminals and cause FTLD-FUS. RESULTS FUS Phase Behavior In Vitro Is Modulated by Salt and FUS Concentration Prior work has established that the LC domain of FUS can form β-sheet-rich condensates when cooled at high protein concentrations (50–133 μM) in the presence of crowding agents (e.g., polyethylene glycol and dextran). However, to gain a quantitative understanding of how regions outside the LC domain might influence the phase behavior of full-length FUS, we expressed and purified wild-type, full-length human FUS from eukaryotic Sf9 cells with or without an Emerald GFP (EmGFP) tag. We chose this system over bacterial production systems because it allows analysis of FUS that has undergone physiological eukaryotic post-translational modification. We then used this material to explore the impact of variations in temperature (4°C–37°C) and salt (50–150 mM NaCl or KCl) at physiological FUS protein concentrations (≤5 μM). These experiments revealed that variations in temperature (4°C–37°C) had little effect on the phase state of full-length FUS at physiological concentrations (∼1 μM). In contrast, FUS phase behavior was profoundly affected by variations in the concentration of salts, such as NaCl and KCl. Specifically, at 1 μM FUS, decreasing concentrations of NaCl or KCl from 150 to 50 mM caused rapid phase separation of FUS into hundreds of small droplets (2.29 ± 0.15 μm diameter; n = 128 assemblies) (Figure 1B). These assemblies, which appeared within seconds, were approximately spherical (Figures 1C–1E), and underwent fusion events that could be monitored using structured illumination microscopy (Figure 1E; Video S1). These effects were not influenced by

Read the complete text